Could ICU Medical, Inc. (ICUI) Go Down After Touching 52-Week High?

June 17, 2018 - By Vivian Currie

ICU Medical, Inc. (NASDAQ:ICUI) Logo

Investors sentiment is 1.19 in Q1 2018. Its the same as in 2017Q4. It is flat, as 22 investors sold ICU Medical, Inc. shares while 81 reduced holdings. only 58 funds opened positions while 65 raised stakes. 14.47 million shares or 4.83% less from 15.21 million shares in 2017Q4 were reported.
Blackrock holds 1.64M shares or 0.02% of its portfolio. Legal And General Grp Inc Public Ltd Co accumulated 0% or 14,980 shares. Gamco Investors Et Al stated it has 63,900 shares. Barrett Asset Mgmt Limited Liability Corporation has 37,215 shares. Shine Advisory Service Inc has invested 0.01% in ICU Medical, Inc. (NASDAQ:ICUI). Schwab Charles Investment Mngmt holds 0.02% of its portfolio in ICU Medical, Inc. (NASDAQ:ICUI) for 80,237 shares. Proshare Advsrs Limited Co stated it has 0.01% of its portfolio in ICU Medical, Inc. (NASDAQ:ICUI). Dimensional Fund Advisors Lp has 314,392 shares for 0.03% of their portfolio. Bogle Inv Mngmt Limited Partnership De holds 37,285 shares or 0.71% of its portfolio. Kirr Marbach And Co Ltd Co In has 2,395 shares for 0.13% of their portfolio. Polar Llp reported 0.32% in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Daiwa Secs Grp Incorporated has 0.03% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 16,624 shares. Zeke Capital Advisors Ltd Limited Liability Company owns 794 shares or 0.02% of their US portfolio. Northern Corporation invested 0.02% in ICU Medical, Inc. (NASDAQ:ICUI). New York State Common Retirement Fund invested in 0.02% or 75,172 shares.

Since January 4, 2018, it had 0 buys, and 12 sales for $41.35 million activity. Sanzone Virginia Ruth had sold 500 shares worth $134,925 on Tuesday, May 15. 6,525 shares valued at $1.65 million were sold by LOPEZ GEORGE A on Thursday, April 5. 1,763 shares were sold by Woolson Daniel, worth $482,480 on Thursday, May 24. Lamb Scott E had sold 23,624 shares worth $5.20M. 698 shares valued at $171,010 were sold by SWINNEY ROBERT S on Friday, March 2.

The stock of ICU Medical, Inc. (NASDAQ:ICUI) hit a new 52-week high and has $326.37 target or 6.00 % above today’s $307.90 share price. The 8 months bullish chart indicates low risk for the $6.25 billion company. The 1-year high was reported on Jun, 17 by Barchart.com. If the $326.37 price target is reached, the company will be worth $375.12M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.60% or $1.85 during the last trading session, reaching $307.9. About 156,115 shares traded or 30.93% up from the average. ICU Medical, Inc. (NASDAQ:ICUI) has risen 73.35% since June 17, 2017 and is uptrending. It has outperformed by 60.78% the S&P500.

Analysts await ICU Medical, Inc. (NASDAQ:ICUI) to report earnings on August, 8. They expect $1.70 EPS, up 226.92 % or $1.18 from last year’s $0.52 per share. ICUI’s profit will be $34.52 million for 45.28 P/E if the $1.70 EPS becomes a reality. After $2.06 actual EPS reported by ICU Medical, Inc. for the previous quarter, Wall Street now forecasts -17.48 % negative EPS growth.

More notable recent ICU Medical, Inc. (NASDAQ:ICUI) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” on June 15, 2018, also Streetinsider.com with their article: “ICU Medical (ICUI) Gains as Smith Group Confirms Early Merger Talks” published on May 29, 2018, Schaeffersresearch.com published: “Dow Futures Higher With ECB, Retail Sales in the Spotlight” on June 14, 2018. More interesting news about ICU Medical, Inc. (NASDAQ:ICUI) were released by: Nasdaq.com and their article: “New Research: Key Drivers of Growth for EPAM, Jernigan Capital, Holly Energy Partners, ICU Medical, San Juan Basin …” published on May 22, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time” with publication date: June 01, 2018.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $6.25 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patientÂ’s vein for use in hospitals and ambulatory clinics. It has a 93.59 P/E ratio. The companyÂ’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: